Core Insights - The "Third China-Korea Enterprise Matching Event" successfully took place, focusing on collaboration in the biopharmaceutical industry between China and South Korea [1] - The event gathered nearly a hundred representatives from major biopharmaceutical companies, specialized enterprises, national economic development zones, and financial institutions [1] Group 1: Event Overview - The event was co-hosted by the Investment Promotion Bureau of the Ministry of Commerce and the Korean Biopharmaceutical Association [1] - Key figures in attendance included Yu Zirong, Deputy Director of the Investment Promotion Bureau, and Lee Seung-gwi, Vice President of the Korean Biopharmaceutical Association [1][2] Group 2: Economic Context - China is showcasing strong economic resilience and potential, emphasizing high-level openness to foreign investment [2] - The "Invest in China" brand has become a crucial platform for multinational companies to understand and engage with the Chinese market [2] Group 3: Collaborative Efforts - The partnership between the Korean Biopharmaceutical Association and the Investment Promotion Bureau has led to the establishment of the "Korean Biopharmaceutical Association China Office" in Beijing [3] - The event highlighted the importance of expanding cooperation channels and platforms for mutual benefits between Chinese and Korean enterprises [3] Group 4: Industry Insights - Discussions included topics on industry upgrades, clinical data, and investment cooperation among leading Korean companies and Chinese institutions [4] - Specific projects in areas such as vaccine microneedles, breast cancer repair treatment, and artificial intelligence technologies attracted significant interest and led to preliminary cooperation intentions [4]